|
|
Volumn 9, Issue 15, 2004, Pages 637-640
|
|
Fighting superbugs with superdrugs
a
a
NONE
|
|
Author keywords
adhesin; Drug Discovery; endogenous route; exogenous route; new molecular entities; Pharmaceutical Science; public private partnerships; vancomycin resistant Staphylococcus aureus
|
|
Indexed keywords
ADHESIN;
ANTIBIOTIC AGENT;
BCG VACCINE;
CHLORAMPHENICOL;
DAPTOMYCIN;
GARENOXACIN;
PROTEINASE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
QX 52525;
S 1562B;
TETRACYCLINE;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
VRT 676327;
ACTINOMYCES NAESLUNDII;
ANTIBIOTIC RESISTANCE;
BACTEREMIA;
CONFERENCE PAPER;
DNA REPLICATION;
DRUG INDUSTRY;
EDUCATION;
ENDOCARDITIS;
FOOD AND DRUG ADMINISTRATION;
GENERAL PRACTICE;
GRAM NEGATIVE BACTERIUM;
GRAM NEGATIVE INFECTION;
GRAM POSITIVE BACTERIUM;
HUMAN;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MUSCLE ATROPHY;
NONHUMAN;
OSTEOMYELITIS;
ADULT;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
CHILD;
CONGRESSES;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
HUMANS;
|
|
EID: 3242769052
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(04)03138-1 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (3)
|
